Subject(s)
Lupus Erythematosus, Systemic , Meningitis, Bacterial , Streptococcal Infections , Strongyloides stercoralis , Strongyloidiasis , Animals , Humans , Strongyloidiasis/complications , Strongyloidiasis/diagnosis , Lupus Erythematosus, Systemic/complications , Streptococcal Infections/complications , Streptococcal Infections/diagnosis , Meningitis, Bacterial/complications , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/drug therapy , Streptococcus gallolyticusABSTRACT
Chronic pulmonary aspergillosis has a range of manifestations from indolent nodules to semi-invasive infection. Patients may be asymptomatic or have chronic symptoms such as cough and weight loss or present with life-threatening haemoptysis. The physician can choose from a range of available therapies including medical therapy with antifungals, minimally invasive therapy with intracavitary antifungal therapy and surgery involving open thoracotomy or video-assisted thoracoscopic surgery. The patients with the most severe forms of pulmonary infection may not be surgical candidates due to their underlying pulmonary condition. The management of haemoptysis can include tranexamic acid, bronchial artery embolisation, antifungals or surgery. There are few controlled studies to inform clinicians managing complex cases, so a multidisciplinary approach may be helpful.